David Griffin, MD
David Griffin, MD
Attending Physician
Anmed Gynecologic Oncology/Upstate Oncology Associates
116 Shire Dr
Anderson,
SC
USA
29621
Papers:
53
A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study